Release Date: May 08, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Annual recurring revenue increased by 51% compared to the previous year's first quarter. Total revenue grew by 37%, with SA license revenue up by 42%. Gross profit rose by 38%, indicating efficient cost management. The company secured several strategic wins, including expansions within existing customers and new partnerships. The NGX platform's versatility is demonstrated by its adoption across various industries, including specialty therapeutics and consumer products.

Negative Points

Operating expenses increased by 21%, which could impact profitability if not managed carefully. The net amount of new ARR in Q1 2025 was slightly down compared to Q1 2024. There is a potential risk of smaller companies experiencing changes differently due to economic conditions. The company is still in the early stages of its partnership with Capgemini, which may take time to show financial impact. Foreign exchange fluctuations had a minor impact on revenue and ARR growth, which could become more significant if exchange rates change.

Q & A Highlights

Warning! GuruFocus has detected 8 Warning Signs with PITAF.

Q: Can you provide context around the incentives for customers to make long-term commitments and the strategic rationale behind them? A: Eddie Ryan, CEO: We've seen larger customers scaling into enterprise licenses, which are contracts for three-year periods. These allow customers to expand their license count over time with incentives to scale quicker. This benefits both the customer and us, as it locks in long-term agreements and facilitates further expansion.

Q: From a modeling perspective, can you help us understand the amount of ARR staging into revenue over time? A: Hugh Cavanaugh, CFO: The key objective is to allow customers to access licenses earlier without being out of pocket. While I won't provide specific numbers, you can look at the difference between quarterly revenue and ARR to get a sense of the staging.

Q: What feedback did you receive from customers at the Validate user conference regarding the R&D roadmap and pipeline generation? A: Eddie Ryan, CEO: The event was very positive, with customers aligned with our vision and strategy. Prospects were excited to engage with existing customers, reinforcing our pipeline. One prospect even decided to encourage their company to go with Kneat after the event.

Q: Are you seeing more diversity in use cases being configured on the platform by existing customers? A: Eddie Ryan, CEO: Yes, customers are expanding beyond core areas like computer system and equipment validation. They are using our platform for various regulated data-intensive documentation processes, which aligns with our strategy to consolidate our leadership in validation.

Story Continues

Q: Can you describe the partnership with Capgemini and its potential impact on future financials? A: Eddie Ryan, CEO: The partnership with Capgemini is in early stages, focusing on expanding Kneat within larger companies. While it will deliver value over time, it won't have an immediate impact on financials.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments